Certificate of Attendance: Advanced Neuraxial Neuromodulation

7:00 AM - 5:00 PM Thursday, January 23

The purpose of the Certificate of Attendance course is to provide an educational platform, offered through NANS, to educate and train physician providers on the evidence-based and appropriate utilization of implantable therapies for pain management (dorsal root ganglion stimulation, spinal cord stimulation, and intrathecal drug delivery). The course will consist of two educational parts, including a hands-on cadaver lab, where implantation techniques are reviewed. Further, attendees will have scheduled didactics focusing on the course learning objectives.

This course is designed for those who have already completed an ACGME fellowship training and are interested in formalizing neuromodulation in their practice.

Interested participants must complete the required application form. Applications will be screened by the course directors for core requirements needed for entry into the program. Typically, candidates will have been in practice and desire to enhance their education on the appropriate utilization and deployment of implantable pain therapies.

CME Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians.

The CNS designates this live activity for a maximum of 9 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the mechanisms of implantable pain therapies.
  • Identify appropriate patient indications and selection criteria for use of spinal cord stimulation and intrathecal drug delivery.
  • Recognize psychological considerations involved in patient selection for implantable neuromodulation therapies.
  • Discuss the preoperative evaluation of patients being considered for implantable neuromodulation therapies.
  • Discuss spinal cord stimulation and dorsal root ganglion stimulation programming troubleshooting.

Core Entrance Requirements:

For non-neurosurgeon trained physicians, the successful completion of an ACGME accredited fellowship in pain management is required for entry into the program.

The applicant must possess privileges or have the ability to obtain privileges for implantable therapies in a Joint Commission accredited hospital setting, properly certified surgical center, or similar facility.

Registration Rates:

Registration on or Before November 4, 2019:

Member: $375
Non-Member: $375

Registration After November 4, 2019:

Member: $475
Non-Member: $475

Application Deadline

The deadline to apply is September 13, 2019.

Apply Today



Cadaver Lab

Working Lunch: Matching the Right Therapy with the Right Patient

Robert M. Levy, MD PhD


Bryan C. Hoelzer, MD

Enhancing Patients Success with Implantable Therapies

David A. Provenzano, MD

Cancer Pain and Intrathecal Therapy

Ashwin Viswanathan, MD

Mechanisms of SCS

Corey W. Hunter, MD FIPP

Device Programming and Troubleshooting

Hemant Kalia, MD MPH FIPP

Non-Infectious Complications: Prevention, Diagnosis, Mitigation Strategies

Eellan Sivanesan, MD

Infection: Prevention, Diagnosis, and Treatment

Stephanie A. Neuman, MD

PACC: Intrathecal Trialing and Long Term Management

Jill Sindt, MD

Faculty and Presentations subject to change.